When we analyzed the GSTM2 expression in tumor cells, we found that the patients with lower GSTM2 immunohistochemical scores frequently had poorer OS (p = 0.12, HR = 1.487, 95%CI (0.9877 - 2.4707) (Figure 7F). Here, GSTM2 is linked to neoplasm.